Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL

Clinical trial NCT00379574 · COMPLETED

Trial details

NCT number: NCT00379574
Sponsor: Asan Medical Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma, Large-Cell, Diffuse Lymphoma, B-Cell

Start date: 2006-09-01
Primary completion: 2011-01-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.